AMIGO2 and digestive system cancer: Later, numerous other studies have reported AMIGO2 expression in gastrointestinal tract cancers, revealing its anti-apoptotic and cell adhesion activities which bestow to the tumor cells a higher metastasis formation capacity (34–38).